Erito-25 Tablet
Cinnarizine 25 mg Tablets — Antihistamine + Calcium Channel Blocker
| Composition | Cinnarizine 25 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 395 |
| Therapy | G.P. + ENT — Antihistamine + Calcium Channel Blocker |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Erito-25 Tablet
Erito-25 Tablet contains Cinnarizine 25 mg — a unique molecule with H1 antihistamine and calcium channel blocker activity, used for vestibular disorders, motion sickness, vertigo and cerebral circulation problems.
Cinnarizine improves vestibular function, reduces vertigo and prevents motion sickness through multiple mechanisms. Widely used in tropical countries for cerebral and peripheral circulatory disorders.
Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- Vertigo and dizziness
- Motion sickness prophylaxis
- Meniere's disease (adjunct)
- Cerebral circulatory disorders
- Peripheral vascular disease
Mechanism of Action
Cinnarizine blocks voltage-gated calcium channels and H1 histamine receptors. Calcium channel blockade in vestibular nuclei reduces vertigo; vascular effects improve cerebral and peripheral microcirculation.
Dosage & Administration
Adults: 25 mg three times daily. Motion sickness: 25 mg 30 minutes before travel.
Side Effects
Drowsiness, dry mouth, weight gain. Extrapyramidal effects in elderly with prolonged use.
Contraindications & Precautions
Hypersensitivity. Parkinson's disease (caution). Pregnancy.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Erito-25 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Erito-25 Tablet used for?
Erito-25 Tablet contains Cinnarizine 25 mg. Used as per the indications described above.
How should Erito-25 Tablet be taken?
As directed by your physician. Complete the prescribed course.
Is Erito-25 Tablet available for PCD pharma franchise?
Yes, Trumac Healthcare offers Erito-25 Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Erito-25 Tablet be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Erito-25 Tablet WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Erito-75 SR Tablet — Cinnarizine 75 mg Sustained Release
- Erito-D Tablet — Cinnarizine 20 mg + Domperidone 15 mg
- Erito-Plus Tablet — Cinnarizine 20 mg + Dimenhydrinate 40 mg